Nicotine Polacrilex Lozenge Mint Lozenge
Product Images NDC 63868-732
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex Lozenge Mint (NDC 63868-732). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chain Drug Marketing Association Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (4 mg Carton)
Fig1 (Fig1)
The text provides a reminder to individuals undergoing smoking cessation using nicotine lozenges, indicating the number of lozenges to be taken at specific intervals during the 12-week period after the quit date. It suggests placing reminders on a calendar for the beginning of week 1 and week 7, where one lozenge should be taken every 1-2 hours during step 1, and one lozenge every 4-8 hours during step 3. Additionally, it advises placing a reminder for the beginning of week 10, where it is not clear what the individual should do.*
Pic1 (Pic1)
The above text is a description of a WALLET CARD that appears to contain emergency help contact information. The card has contact details for the American Lung Association, the American Cancer Society, and the American Heart Association. The card also includes a reference to a "Quitting Buddy or Friend who has Quit," which may suggest that the card is meant to help individuals quit smoking. Overall, the text provides limited information but could be useful for someone looking for quick access to these helplines.*
Pic2 (Pic2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.